A blood test that measures SARS-CoV-2 RNA when patients are admitted to the hospital with COVID-19 symptoms can be a powerful diagnostic tool to predict how...
Brazil's COVID-19 death toll appears to be easing for the first time since May, data shows, a sign the Latin American country could be descending from...
A Melbourne study has revealed watching more than two hours of TV or spending more than one hour on a computer per day negatively impacts a...
A new study from Iceland provides reassurance that our antibodies to the coronavirus that causes covid-19 can last at least four months — assuming that we...
Daily new COVID-19 infections in France have neared an all-time high and the number of people hospitalised in intensive care units for the disease has grown...
More likely to be asymptomatic, yet overt illness more severe; are skewed data the reason?
Type 2 diabetes affects about one million Australian adults and 400 million people globally, with that figure rising fast. It causes high blood glucose...
Dr. Chiaravalloti: 'People with progressive MS appeared to have adapted more effectively to the lockdown conditions. Knowing their increased risk, they may have been early adopters...
Daily new COVID-19 infections in France have neared an all-time high and the number of people hospitalised in intensive care units for the disease has grown...
PHILADELPHIA — An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and...